ELV vs CI — Key Metrics
| Metric | ELV (ELEVANCE HEALTH INC) | CI (CIGNA GROUP) |
|---|---|---|
| Price | 400.84 | 285.37 |
| Market Cap | 86.6 Billion | 75.2 Billion |
| P/E (TTM) | 16.97 | 12.53 |
| P/B (Quarterly) | 2.099 | 1.831 |
| P/S (TTM) | 0.43 | 0.26 |
| Net Profit Margin (TTM) | 2.5 | 2.1 |
| Gross Margin (TTM) | 15.5 | 9.1 |
| ROE (TTM) | 11.6 | 14.1 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Outperform
Greatly Outperform
Recommendation Summary
Stock ELV is projected to outperform the market, stock CI is projected to greatly outperform the market. Upfront Recommendation: CI.
Financial Metrics
| ELV | Metrics | CI |
|---|---|---|
| $400.84 | Price | $285.37 |
| — | Market Capitalization | — |
| 16.97 | Price to Earnings Ratio | 12.53 |
| 0.43 | Price to Sales | 0.26 |
| 13.3 | Price to FCF Ratio | 9.1 |
| 2.77 | Price to Gross Profit | 2.89 |
| 1.26 | Price to Current Assets | 1.59 |
ELV vs CI at a glance
Elevance Health INC (ELV) and Cigna Group (CI) are both Healthcare Plans companies in the Healthcare sector. ELV is the larger, at $86.6 billion in market value against $75.2 billion for CI, about 1.2 times the size.
On trailing-twelve-month figures, ELV trades at 17.0 times trailing earnings and CI at 12.5; net profit margins are 2.5% and 2.1%.
The Upfront Investment model currently rates ELV Outperform and CI Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.